Center for Continuing Education
UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

UNMC Transplant Symposium (Attendee Information)

This site is intended for registered participants of the UNMC Transplant Symposium.

UNMC Transplant Symposium

Welcome! Thank you for joining us.

The University of Nebraska Medical Center has a strong history of caring for patients with end-stage organ failure and transplantation as a curative treatment. The unique opportunity for UNMC as a transplant center is the presence of an active clinical program in all forms of solid organ transplant, including heart, lung, liver, kidney, and intestine.

The care and treatment of transplant patients require a multidisciplinary and interprofessional approach. Collaborative innovation in clinical care, as well as research from a foundational, translational, and clinical nature, holds the promise of a positive impact on patient outcomes.

This symposium will provide opportunities for internal collaboration and external engagement for the transplant programs at UNMC and Nebraska Medicine and create a framework to lead the world in transforming lives to create a healthy future for all individuals and communities affected by end-stage organ failure.

Symposium Objectives

At the conclusion of this activity, the participant should be better able to:

  1. Review the current state-of-the-art approach to interdisciplinary care in solid organ transplantation.
  2. Evaluate emerging research, trends, and clinical practices related to solid organ transplantation.
  3. Identify opportunities for clinical and research collaboration, discovery, and program development in solid organ transplantation.

General Information

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

  • Jay A. Fishman, MD
    Consultant: eGenesis, Makana, Sfunga Therapeutics, United Therapeutics
    Author: UpToDate
  • Carlos A. Gomez, MD
    INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Foscarnet, Letermovir, Maribavir
  • Eric D. Langewisch, MD
    Principal Investigator in clinical trial: CareDX, Inc., CSL Behring
    Sub-Investigator in clinical trial: Natera, Inc., Transplant Genomics, Inc.
  • Mary Leick, PharmD, BCPS, BCTXP*
    Consultant: DynaMed
  • Brian Lowes, MD, PhD*
    Research: Abiomed, CareDX, Inc.
  • Roslyn B. Mannon, MD*
    Consultant: CSL Behring, HI-BIO, Sanofi, Verici Dx 
  • Shaheed Merani, MD, PhD, FRCS(C), FACS*
    Site PI for Research: CareDX, Inc., Paragonix Technologies, Inc., TransMedics
  • Clifford D. Miles, MD
    Consultant/Research funding: Eurofins Viracor, LLC
  • Marco A. Olivera-Martinez, MD
    INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Terlipressin/Portal Hypertensive Hemorrhage
  • Ruben E. Quiros, MD*
    Consultant: Albireo Pharma Inc., Mirum Pharmaceuticals
  • Scott G. Westphal, MD
    Research PI (receive no personal funds): Eledon Pharmaceuticals, Inc., ITB-MED, Natera, Inc., Transplant Genomics Inc.
  • Jingwei Xie, PhD
    Receiving Royalties: Acera Surgical, Inc.

The following have nothing to disclose:

  • Brian J. Benes, DO*
  • Katherine Brodahl, PA-C*
  • Mary K. Clark, MSN, RN, CCTC, C-EFM
  • Natalia E. Castillo Almeida, MD*
  • Jason M. Cole, MD
  • Jesse L. Cox, MD, PhD
  • Harris A. Frankel, MD
  • Wendy J. Grant, MD, FACS
  • Molly E. Henry, PharmD, BCTXP
  • Kyle Herber
  • Marshall P. Hyden II, MD
  • Cale A. Kassel, MD
  • Nathalie Khoury, MD
  • Alan N. Langnas, DO, FACS*
  • Alexander T. Maskin, MD, FACS
  • Faruq Pradhan, MBBCh, FRCPC*
  • Emille Reyes-Santiago, MD
  • Nora E. Sarvetnick, PhD
  • Aleem Siddique, MBBS, FACS, FACC
  • Abigail Servais, PharmD, BCTXP*
  • John Stallbaum
  • Veronica A. Taylor, MD, MS
  • Marian Urban, MD, PhD
  • Sara Zachman, MD, MPH

PLANNING COMMITTEE

The following have disclosed relevant financial relationships:

  • Morgan Moody, BSN
    Speaker: Abbott

The following have nothing to disclose:
  • Valeta Creason-Wahl, HMCC
  • Tracy Hanzek
  • Heidi Keeler, PhD, MSN/MBA, RN
  • Megan Keck, PharmD, BCPS, BCTXP
  • Joshua Mischo
  • Renee Paulin, MSN, RN, CWOCN
  • Brenda Ram, CMP, CHCP

*Faculty and planning committee member

Requirements for Successful Completion

In order to receive continuing education credits, you must:

  1. Check in at the registration desk and attend the live activity.
  2. Complete the online evaluation via the UNMC MyCCE portal.
    • On your dashboard, click Evaluate an Activity.
    • Enter Activity Code 61779.

You have until March 28, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.

Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account

Symposium Director

Alan N. Langnas, DO, FACS

Professor of Surgery
Chief, Division of Transplant Surgery, Department of Surgery, UNMC

Alan N. Langnas, DO, FACS

Questions?

Brenda Ram, CMP, CHCP

Director, Educational Programs
UNMC Center for Continuing Education

402-559-9250

Brenda Ram, CMP, CHCP